Last updated on February 2018

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency


Brief description of study

To Evaluate the safety and efficacy of PEG Somatropin in the treatment of children with growth hormone deficiency, as well as to study the dosage of PEG Somatropin.

Clinical Study Identifier: NCT03249480

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.